61560-98-3

Upstream product

• 14347-05-8 4-benzyloxy-3-nitroacetophenone 
• 61873-94-7 4-Benzyloxy-3-nitrophenylessigsaeure 
• 861306-34-5 4-ethoxycarbonyloxy-3-nitro-benzoic acid 
• 861377-45-9 4-ethoxycarbonyloxy-3-nitro-benzoyl chloride 
• 616-82-0 3-nitro-4-hydroxybenzoic acid 
• 61560-90-5 2-(3-nitro-4-benzyloxyphenyl)glyoxylic acid 

Downstream Products

• 66340-57-6 (4-Hydroxy-3-nitro-phenyl)-[(Z)-methoxyimino]-acetic acid methyl ester 
• 66340-58-7 (4-Hydroxy-3-nitro-phenyl)-[(Z)-methoxyimino]-acetic acid 

Relevant academic research and scientific papers

Syn isomer of 7-[2-cyclo(lower) alkoxyimino-2-(2-amino-or substituted aminothiazol-4-yl)acetamido]-3-lower alkanoyloxymethyl or heterocyclicthiomethyl-3-cephem-4-carboxylic acid compounds

Syn isomers of 3-substituted 7-[2-substituted imino-2-substituted acetamido]-3-cephem-4-carboxylic acid and salt bacteriostatic-compounds and pharmaceutical compositions thereof and processes for preparing same.

Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof

Preparation of pharmaceutical composition comprising, treatment of human and animal diseases with, and compound of, 3,7-disubstituted-3-cephem-4-carboxylic acid.

7[(2-Hydroxyamino-2-disubstituted phenyl-acetamido)-]3-heterocyclicthio-3-cephem-4-carboxylic acids

The new 7-(α,α-disubstituted-acetamido)-3-substituted-3-cephem-4-carboxylic acid of the present invention is represented by the following formula: STR1 wherein R1 is hydrogen, halogen, hydroxy, nitro, lower alkoxy or acylamino, R2 is hydrogen or acyl and R3 is lower alkanoyloxy, carbamoyloxy which may have lower alkyl, aryl or protective group for amino, or a heterocyclicthio which may have lower alkyl, aryl or protective group for amino, or a hetero- which may have lower alkyl.

Syn 7-oxoimino substituted derivatives of cephalosporanic acid

The present invention relates to new syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and pharmaceutically acceptable salts thereof. More particularly, it relates to new syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and pharmaceutically acceptable salts thereof which have antibacterial activities and to processes for the preparation thereof, to pharmaceutical composition comprising the same, and to a method of using the same therapeutically in the treatment of infectious diseases in human beings and animals.